Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1437-160X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis ; day:5 ; month:2 ; year:2019 ; pages:1
Rheumatology international ; (5.2.2019), 1

Creator: Bykerk, Vivian P.
Burmester, Gerd R.
Combe, Bernard G.
Furst, Daniel E.
Huizinga, Tom W. J.
Ahmad, Harris A.
Emery, Paul

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00296-018-4232-9

URN: urn:nbn:de:101:1-2019031223203916918238

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bykerk, Vivian P.
Burmester, Gerd R.
Combe, Bernard G.
Furst, Daniel E.
Huizinga, Tom W. J.
Ahmad, Harris A.
Emery, Paul
SpringerLink (Online service)

Other Objects (12)

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry

Investigation of Potential Drug–Drug Interactions between Peficitinib (ASP015K) and Methotrexate in Patients with Rheumatoid Arthritis

A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs : : a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs : a descriptive analysis of data from interventional trials and the real-world setting

Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis

Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate

Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis

Drug–Drug Interactions with Direct Oral Anticoagulants

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry

Investigation of Potential Drug–Drug Interactions between Peficitinib (ASP015K) and Methotrexate in Patients with Rheumatoid Arthritis

A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs : : a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs : a descriptive analysis of data from interventional trials and the real-world setting

Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis

Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate

Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis

Drug–Drug Interactions with Direct Oral Anticoagulants

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry

Investigation of Potential Drug–Drug Interactions between Peficitinib (ASP015K) and Methotrexate in Patients with Rheumatoid Arthritis

A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs : : a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs : a descriptive analysis of data from interventional trials and the real-world setting

Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis

Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate

Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis

Drug–Drug Interactions with Direct Oral Anticoagulants

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis

Show object

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry

Investigation of Potential Drug–Drug Interactions between Peficitinib (ASP015K) and Methotrexate in Patients with Rheumatoid Arthritis

A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs : : a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs : a descriptive analysis of data from interventional trials and the real-world setting

Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis

Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate

Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis

Drug–Drug Interactions with Direct Oral Anticoagulants

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry

Investigation of Potential Drug–Drug Interactions between Peficitinib (ASP015K) and Methotrexate in Patients with Rheumatoid Arthritis

A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs : : a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs : a descriptive analysis of data from interventional trials and the real-world setting

Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis

Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate

Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis

Drug–Drug Interactions with Direct Oral Anticoagulants

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry

Investigation of Potential Drug–Drug Interactions between Peficitinib (ASP015K) and Methotrexate in Patients with Rheumatoid Arthritis

A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs : : a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs : a descriptive analysis of data from interventional trials and the real-world setting

Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis

Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate

Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis

Drug–Drug Interactions with Direct Oral Anticoagulants

Related objects

Reset password